Joe Biden health update: US President completes 4th dose of PAXLOVID after Covid-19 diagnosis
Joe Biden health update: US President Joe Biden tested Covid positive on Wednesday, a day after he attended the NAACP National Convention in Las Vegas, where he strongly criticised Donald Trump's policies and also condemned the increase in gun violence in the nation.
In a recent update, Joe Biden completed his fourth dose of PAXLOVID after COVID-19 diagnosis
Biden's doctor Kevin C O'Connor said that Biden continues to face primary symptoms like a loose, non-productive cough and hoarseness. However, his symptoms have "improved meaningfully" since Thursday.
In a statement released by the White House on X, Kevin C O'Connor said, "President Biden completed his fourth dose of PAXLOVID this morning. His loose, non-productive cough and hoarseness continue to be his primary symptoms, but they have improved meaningfully from yesterday. His pulse, blood pressure, respiratory rate and temperature remain absolutely normal. His oxygen saturation continues to be excellent on room air. His lungs remain clear."
"Polymerase Chain Reaction (PCR) testing yesterday was confirmatory for SARS-CoV -2 (COVID-19). Variant identification is still pending. All of his bloodwork was normal," the statement said.
Joe Biden's complete blood count (CBC) was normal, showcasing no anaemia or evidence of bacterial infection, it said.
President Biden, 81, has been isolating at his home in Rehoboth Beach, Delaware, after testing positive for COVID-19 on Wednesday while campaigning in Las Vegas. According to the White House, Biden is vaccinated and has received COVID-19 booster shots, the latest in September 2023.
Amid increasing calls for him to drop out of the race, Biden remains determined to defeat Trump in the upcoming election. These calls have grown louder, with Senator Martin Heinrich becoming the third Democratic senator to urge Biden to withdraw, and four House Democrats releasing a joint statement on Friday, urging the president to end his reelection bid.
- With inputs from agencies
